Back

Company Description

We are an oncology-focused biopharmaceutical company dedicated to improving 
the lives of cancer patients. We have in-licensed and are currently developing 
three product candidates, rolapitant, niraparib and TSR-011. We intend to 
continue to leverage the experience and competencies of our senior management 
team to identify, acquire, develop and commercialize cancer therapeutics and 
oncology supportive care products that are safer and more effective than 
existing treatments. Upon successful development and regulatory approval of 
any of our product candidates we intend to make them available to cancer 
patients in North America, Europe and China through our own commercialization 
efforts and to establish a network of licensees and distributors in other 
geographic areas. 

---------

We were incorporated under the laws of the State of Delaware in March 2010. 
Our principal executive offices are located at 1000 Winter Street, Suite 3300, 
Waltham, Massachusetts 02451, and our telephone number is (339) 970-0900. Our 
website address is www.tesarobio.com.
More

Copyright 2013, EDGAR Online, Inc. All rights reserved. Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.